H.C. Wainwright analyst Edward White downgraded Vyant Bio to Neutral from Buy without a price target after the company announced a workforce reduction to preserve cash. The analyst cites the change in management along with the uncertainty surrounding exploring strategic alternatives for the downgrade.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on VYNT:
